Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cullinan Therapeutics (CGEM) Accumulated Expenses: 2020-2022

Historic Accumulated Expenses for Cullinan Therapeutics (CGEM) over the last 3 years, with Dec 2022 value amounting to $14.1 million.

  • Cullinan Therapeutics' Accumulated Expenses rose 55.08% to $20.9 million in Q3 2023 from the same period last year, while for Sep 2023 it was $20.9 million, marking a year-over-year increase of 55.08%. This contributed to the annual value of $14.1 million for FY2022, which is 64.80% up from last year.
  • Latest data reveals that Cullinan Therapeutics reported Accumulated Expenses of $14.1 million as of FY2022, which was up 64.80% from $8.6 million recorded in FY2021.
  • Over the past 5 years, Cullinan Therapeutics' Accumulated Expenses peaked at $14.1 million during FY2022, and registered a low of $4.6 million during FY2020.
  • For the 3-year period, Cullinan Therapeutics' Accumulated Expenses averaged around $9.1 million, with its median value being $8.6 million (2021).
  • Data for Cullinan Therapeutics' Accumulated Expenses shows a peak YoY surged of 84.81% (in 2021) over the last 5 years.
  • Yearly analysis of 3 years shows Cullinan Therapeutics' Accumulated Expenses stood at $4.6 million in 2020, then surged by 84.81% to $8.6 million in 2021, then skyrocketed by 64.80% to $14.1 million in 2022.